In vitro hemolytic effect of sulfadoxine/pyrimethamine and artemether/lumefantrine on malaria parasitized erythrocytes of female patients

Pakistan Journal of Pharmaceutical Sciences

Volumn 25, Issue 4, 2012, Pages 851-855

  Anaba, Festus Chinyereugo ^a   Ahiante, Blessing Osemengbe ^a   Pepple, Dagogo John ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Coartem; Fansidar; Females; Hemolysis; Malarious; Non malarious

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PYRIMETHAMINE PLUS SULFADOXINE; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FANASIL, PYRIMETHAMINE DRUG COMBINATION; FLUORENE DERIVATIVE; PYRIMETHAMINE; SULFADOXINE; TRANQUILIZER;

ADULT; ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALARIA; NIGERIA; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; PARASITOLOGY;

ADULT; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; ARTEMISININS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ERYTHROCYTES; ETHANOLAMINES; FEMALE; FLUORENES; HEMOLYSIS; HUMANS; MALARIA; MIDDLE AGED; NIGERIA; PYRIMETHAMINE; SULFADOXINE; YOUNG ADULT;

EID: 84871860917     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ali MSM and Kadaru AGMY (2005). In vitro processing for donor blood with sulfadoxine-pyrimethamine for eradication of transfusion-induced malaria. Am. J. Trop. Med. Hyg., 73: 1119-1123.
2. Beutler E, Dupare S and G6PD Working Group. (2007). Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am. J. Trop. Med. Hyg., 77: 779-789.
3. Chikezie PC, Uwakwe AA and Monago CC (2009). Studies of human HbAA erythrocyte osmotic fragility index of non-malarious blood in the presence of five antimalarial drugs. J. Cell Anim. Biol., 3: 39-43.
4. Chikezie PC, Uwakwe AA and Monago CC (2010). Comparative osmotic fragility of three erythrocyte genotypes (HbAA, HbAS and HbSS) of male subjects/volunteers administered with five antimalarial drugs. Asian J. Exp. Biol. Sc., 2: 378-386.
5. Gupta S and Saxena KC (1980). In vitro hemolytic activity of plasmodium berghei on red blood cells. J. Biosci., 2: 129-134.
6. Johanning GL and O'Dell BL (1989). Effect of zinc deficiency and food restriction in rats on erythrocyte membrane zinc, phospholipid and protein content. J. Nutr., 119: 1654-1660.
7. Kumar S (2002). An analogy for explaining erythrocyte fragility: concepts made easy. Adv. Physiol. Educ., 26: 134-135.
8. Luzzatto L (2002). Glucose-6-phosphate dehydrogenase deficiency: From genotype to phenotype. Haematologica, 91: 1303-1306.
9. Meshnick SR, Thomas A, Ran A, Xy CM and Pan HZ (1991). Artemisini (qinghaosu): The role of intracellular hemin in its mechanism of antimalarial action. Mol. Biochem. Parasitol., 49: 181-189.
10. Nosten F and White NJ (2007). Artemisinin-based combination treatment of falciparum malaria. Am. J. Trop. Med. Hyg., 77(6 Suppl): 181-192.
11. Snow RW, Guerra CA, Noor AM, Myint HY and Hay SI (2005). The global distribution of clinical episodes of plasmodium falciparum malaria. Nature, 434: 214-217.
12. World Malaria Report (2008). World Health Organisation, Geneva.